15440811000001105: Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) (product)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Actual medicinal product\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\UK product\Virtual medicinal product\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\UK product\Virtual therapeutic moiety\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\UK product\Trade family\Stalevo\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)

\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing dihydroxyphenylalanine decarboxylase inhibitor\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing enzyme inhibitor\Product containing transferase inhibitor\Product containing methyltransferase inhibitor\Product containing catechol-O-methyltransferase inhibitor\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by disposition\Product containing dopamine receptor agonist\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing catecholamine\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing nitrogen and/or nitrogen compound (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by structure\Product containing phenol structure (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing carbidopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing entacapone\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiparkinson agent (product)\Product containing levodopa\Product containing carbidopa and levodopa\Product containing carbidopa and entacapone and levodopa\Levodopa + Carbidopa + Entacapone\Generic Stalevo 75mg/18.75mg/200mg tablets\Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

54760201000001114 Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

54760301000001117 Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has excipient	Excipient not declared	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator	NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Is a	Generic Stalevo 75mg/18.75mg/200mg tablets	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	VMP prescribing status (attribute)	Never valid to prescribe as a VMP	false	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has excipient	Polysorbate	false	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Is a	Stalevo	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has specific active ingredient	Carbidopa	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has specific active ingredient	Entacapone	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has specific active ingredient	Levodopa	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Is a	Actual medicinal product	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) 30 tablet	Has AMP	True	Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier
Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) 100 tablet	Has AMP	True	Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
54760201000001114	Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd) (product)	en	Fully specified name	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module
54760301000001117	Stalevo 75mg/18.75mg/200mg tablets (Orion Pharma (UK) Ltd)	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom drug extension module